Innovative medicine and research: ethical, legal and regulatory issues
Le tecnologie emergenti in genetica, farmacogenetica, genomica, terapie avanzate e applicazioni ICT rappresentano oggi gli strumenti più avanzati utilizzati nella scoperta di farmaci e nel processo di ricerca e sviluppo per produrre la maggior parte dei farmaci innovativi.
Pertanto, la normativa e le guide devono essere continuamente adattati ed aggiornate per garantire benefici clinici, economici e miglioramenti negli esiti sanitari, così come il rispetto dei diritti fondamentali e dei pazienti. Questioni legali, etiche e regolatorie dell’innovazione nel settore medico e sanitario saranno analizzati durante il workshop.
27 Settembre 2019 - Agenda
Messaggio di benvenuto
Adriana Ceci, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus (Italy)
Annagrazia Altavilla, European Association of Health Law (France)
Laurence Lwoff, Head of the Bioethics Unit – Human Rights Directory – Council of Europe (France)
SESSIONE DI APERTURA
Models of Governance for Innovation in Medicine and Health Research
Siobhán O’ Sullivan, Royal College of Surgeons (Ireland)
SESSION I – Innovative medicine and research
Chairman
Timo Minssen, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenaghen – Denmark
Access to Personal Data for Scientific Research in the perspective of innovative medicines
Jean Herveg, University of Namur (Belgium)
Legal and Regulatory issues dealing with paediatric specificity in the EPTRI (European Paediatric Translational Research) framework
Olga Tzortzatou, Biomedical Research Foundation of the Academy of Athens (Greece)
Intellectual Property Protection of Genetic Material and Information in the Pharmaceutical Sector? – Legal Questions on Genetic Material and Genome Sequencing between Innovation, Protection and Sharing
Claudia Seitz, University of Basel (Switzerland), University of Bonn’s Centre for the Law of Life Sciences (Germany)
Pausa
SESSIONE II – Access to health care and innovation
Chairman
Joaquin Cayon De Las Cuevas, University of Cantabria (Spain)
Health Technology Assessment (HTA) and access policies
Verena Stühlinger, University for Health Sciences, Medical Informatics and Technology (UMIT) – (Austria)
Machine Learning Systems applied to health data
Fedele Bonifazi, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus (Italy)
Exploring solutions to foster ATMP’s development and access to patients in Europe
Vincenzo Salvatore, University of Insubria (Italy)
SESSIONE III – Empowerment and patients’ rights in innovative healthcare
Chairman
Tom Goffin, Ghent University (Belgium)
Orphan medicinal products and health budgets: our role as patient advocates
François Houyez, EURORDIS (France)
Health vulnerability and the European framework on access to orphan medicines
Eloise Gennet, INSERM UMR 1027, University of Toulouse (France)
Discussione e conclusione
Chairman
Enrico Bosone, SIARV (Italy)
Annagrazia Altavilla, Espace Ethique PACA-Corse/AP-HM, European Association of Health Law (France)
Annagrazia Altavilla | European Association of Health Law
Fedele Bonifazi | Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus
Scientific Secretary
Antonella Didio | Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus
Organizzato da
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus
European Association of Health Law
Espace éthique
.
Bookings
Bookings are closed for this event.
